Novo Nordisk @ Pfizer

Discussion in 'Pfizer' started by anonymous, Nov 28, 2016 at 9:13 PM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    Novo Nordisk is ready for Pfizer. World's best diabetes products and pipeline and great market reach in Europe and Asia but fallen completely apart in the US (see Cafepharma board) and with Danish management and controlling A shares out of solutions. Perfectly complementary to Pfizer without any anti-trust issues like Eli Lilly and Sanofi.
     

  2. anonymous

    anonymous Guest

    PFE could use $16B new revenue, solid strengthening of the pipeline and market leadership in China and Europe.PFE would be able to beat LLY and SNY in the US diabetes and obesity markets like no one else.
     
  3. anonymous

    anonymous Guest

    Great observation. Unfortunately I do not think our management has the foresight and Danish connections necessary to bring home that bacon.
     
  4. anonymous

    anonymous Guest

    Its an easy decision, one that even our nincompoop leadership can make. We have tons of cash from the past 6 years of Viagra sales alone! (thanks to steady and regular price increases)